The regulatory and legal status of BPC-157 is that of an unapproved research compound in the United States and in most global jurisdictions, with no marketing authorization from any major regulatory agency for human therapeutic use
DSIP flux across the BMEC monolayers was also found to be bidirectional, insensitive to metabolic inhibitors, and not altered by high concentrations of tryptophan
Inadequate lysine intake can reduce protein utilization, impair growth and muscle maintenance, and limit performance capacity
Deficiency of glutathione puts the cell at risk for oxidative damage
Oracea may cause a change in tooth color, especially in children or with long-term use
Regardless of the etiology, plasma concentrations of free carnitine 20 mol/L and increased acylcarnitine/free carnitine ratios (0.4) are considered abnormal (6)